Extracellular adenosine enhances the ability of PMNs to kill Streptococcus pneumoniae by inhibiting IL‐10 production

Polymorphonuclear leukocytes (PMNs) are crucial for initial control of Streptococcus pneumoniae (pneumococcus) lung infection; however, as the infection progresses their persistence in the lungs becomes detrimental. Here we explored why the antimicrobial efficacy of PMNs declines over the course of infection. We found that the progressive inability of PMNs to control infection correlated with phenotypic differences characterized by a decrease in CD73 expression, an enzyme required for production of extracellular adenosine (EAD). EAD production by CD73 was crucial for the ability of both murine and human PMNs to kill S. pneumoniae. In exploring the mechanisms by which CD73 controlled PMN function, we found that CD73 mediated its antimicrobial activity by inhibiting IL‐10 production. PMNs from wild‐type mice did not increase IL‐10 production in response to S. pneumoniae; however, CD73−/− PMNs up‐regulated IL‐10 production upon pneumococcal infection in vitro and during lung challenge. IL‐10 inhibited the ability of WT PMNs to kill pneumococci. Conversely, blocking IL‐10 boosted the bactericidal activity of CD73−/− PMNs as well as host resistance of CD73−/− mice to pneumococcal pneumonia. CD73/IL‐10 did not affect apoptosis, bacterial uptake, and intracellular killing or production of antimicrobial neutrophil elastase and myeloperoxidase. Rather, inhibition of IL‐10 production by CD73 was important for optimal reactive oxygen species (ROS) production by PMNs. ROS contributed to PMN antimicrobial function as their removal or detoxification impaired the ability of PMNs to efficiently kill S. pneumoniae. This study demonstrates that CD73 controls PMN antimicrobial phenotype during S. pneumoniae infection. Extracellular adenosine produced by CD73 promotes the ability of PMNs to kill Streptococcus pneumoniae by blunting IL‐10 production